← Open Payments lookup

JENNIFER PATE: Open Payments

NPI 1972048304 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$418 in 25 payments from 9 companies in 2025. Trend: 2023 $905 · 2024 $1,312 · 2025 $418

Food & beverage: $418
CompanyPaymentsAmount
GlaxoSmithKline, LLC.11$150
PFIZER INC.4$81
Pulmonx Corporation4$72
La Jolla Pharmaceutical Company1$22
Verona Pharma, Inc.1$21
Boehringer Ingelheim Pharmaceuticals, Inc.1$20
GENZYME CORPORATION1$18
Novocure Inc.1$18
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: TRELEGY ELLIPTA, CHARTIS CATHETER, ELIQUIS, GIAPREZA, Ohtuvayre, NUCALA, AREXVY, DUPIXENT.

Industry payments across MS — which companies pay providers there.